0001628280-24-019490.txt : 20240501 0001628280-24-019490.hdr.sgml : 20240501 20240501103125 ACCESSION NUMBER: 0001628280-24-019490 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240501 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: YIELD10 BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001121702 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043158289 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33133 FILM NUMBER: 24900872 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617-583-1700 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX, INC. DATE OF NAME CHANGE: 20060717 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX INC DATE OF NAME CHANGE: 20000810 8-K 1 yten-20240501.htm 8-K yten-20240501
0001121702FALSE12/3100011217022024-05-012024-05-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 
Date of Report (Date of earliest event reported) May 1, 2024
 
YIELD10 BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 

Delaware001-3313304-3158289
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
19 Presidential Way, Woburn, Massachusetts
 01801
(Address of principal executive offices)(Zip Code)
 
Registrant’s Telephone Number, Including Area Code: (617) 583-1700 
N/A 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.01 per shareYTEN
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o




Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On May 1, 2024, Yield10 Bioscience, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-24. The Certificate of Amendment, approved by stockholder approval at the special meeting of stockholders held on April 26, 2024, will become effective as of 5:00 p.m. Eastern Time, after the close of trading on the Nasdaq Capital Market, on May 2, 2024.
As a result of the reverse stock split, every 24 shares of the Company’s pre-reverse split common stock will be combined and reclassified into one share of common stock. No fractional shares will be issued in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive a fractional share in connection with the reverse stock split will receive a cash payment in lieu thereof. In addition, proportionate adjustments will be made to the per-share exercise price and the number of shares issuable upon the exercise of all outstanding stock options, warrants, rights, and other convertible securities, and to the number of shares issued and issuable under the Company’s stock incentive plans.
Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “YTEN.” The new CUSIP number for the common stock following the reverse stock split will be 98585K854.
The Company’s transfer agent, Equiniti Trust Company, is acting as exchange agent for the reverse stock split.
The summary of the Certificate of Amendment contained herein does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is attached as Exhibit 3.1 of this Current Report on Form 8-K and incorporated herein by reference.
Item 8.01 Other Events.
On May 1, 2024, the Company issued a press release with respect to the reverse stock split described above, a copy of which is being filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit  Ma
No. Description
Certificate of Amendment to the Amended and Restated Certificate of Incorporation
 Press Release dated May 1, 2024




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  YIELD10 BIOSCIENCE, INC.
   
May 1, 2024By:/s/ Oliver P. Peoples
  Oliver P. Peoples
  President & Chief Executive Officer


 EX-3.1 2 exhibit31-ytenx20240501xxc.htm EX-3.1 Document

Exhibit 3.1


CERTIFICATE OF AMENDMENT TO EFFECT REVERSE STOCK SPLIT
Pursuant to Section 242 of the General Corporation Law of the State of Delaware, Yield10 Bioscience, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows:
1.The name of the Corporation is Yield10 Bioscience, Inc.
2.The Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on September 1, 1998. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on November 15, 2006, and thereafter, Certificates of Amendment were filed on October 30, 2014, May 26, 2015, January 6, 2017, May 25, 2017, December 27, 2017, May 23, 2018 and January 15, 2020 with the Secretary of State of the State of Delaware.
3.The Corporation’s Amended and Restated Certificate of Incorporation, as amended, is hereby further amended striking out the second paragraph of Article IV and replacing it with the following paragraph:
“Upon effectiveness of this Certificate of Amendment (the “Effective Time”), the shares of Common Stock issued and outstanding immediately prior to the Effective Time and the shares of Common Stock issued and held in the treasury of the Corporation immediately prior to the Effective Time are reclassified into a smaller number of shares such that each twenty-four (24) shares of issued Common Stock immediately prior to the Effective Time is reclassified into one (1) share of Common Stock. Notwithstanding the immediately preceding sentence, no fractional shares shall be issued as a result of the reverse stock split. Instead, any stockholder who would otherwise be entitled to a fractional share of our Common Stock as a result of the reclassification shall be entitled to receive a cash payment equal to the product of such resulting fractional interest in one share of our Common Stock multiplied by the closing trading price of our Common Stock on the trading day immediately preceding the effective date of the reverse stock split. Notwithstanding the foregoing, the Corporation shall not be obliged to issue certificates evidencing the shares of Common Stock outstanding as a result of the reverse stock split or cash in lieu of fractional shares, if any, unless and until the certificates evidencing the shares held by a holder prior to the reverse stock split are either delivered to the Corporation or its transfer agent, or the holder notifies the Corporation or its transfer agent that such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates.”
4.The Amendment of the Amended and Restated Certificate of Incorporation, as amended, herein certified has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
5.This Certificate of Amendment shall be effective on May 2, 2024 at 5:00 p.m., Eastern Time.
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its duly authorized officer on this 1st day of May 2024.
YIELD10 BIOSCIENCE, INC
By:/s/ Oliver P. Peoples
Name:Oliver P. Peoples
Title:President and Chief Executive Officer

 EX-99.1 3 exhibit991-ytenx20240501xx.htm EX-99.1 Document

yield10logoa50.jpg


Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
WOBURN, Mass. – May 1, 2024 – Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a 1-for-24 reverse stock split of its common stock, following stockholder approval of the reverse stock split at its special stockholder meeting held on April 26, 2024. The 1-for-24 reverse stock split will be effective as of 5:00 p.m. Eastern Time, after the close of trading on the Nasdaq Capital Market, on Thursday, May 2, 2024, and the Company's common stock will begin trading on a split-adjusted basis on Friday, May 3, 2024.
The reverse stock split will reduce the number of shares of the Company’s common stock currently outstanding from 15,420,951 shares to 642,539 shares.
Proportional adjustments will be made to the Company’s outstanding stock options, warrants and restricted stock units and to the number of shares issued and issuable under the Company's equity compensation plans. The number of authorized shares of the Company's common stock will remain 60 million shares.
The reverse stock split is intended to increase the market price per share of the Company’s common stock to allow the Company to maintain the listing of its common stock on The Nasdaq Capital Market. The Company's common stock will continue to trade on The Nasdaq Capital Market under the symbol "YTEN." The new CUSIP number for the common stock following the reverse stock split will be 98585K854.
Information for Stockholders
Upon the effectiveness of the reverse stock split, each 24 shares of the Company's issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.01 per share. The reverse stock split will not modify the rights or preferences of the common stock. No fractional shares of common stock will be issued as a result of the reverse split. Instead, stockholders who otherwise would be entitled to receive fractional shares will be entitled to receive cash in an amount equal to the product obtained by multiplying (i) the closing price of Yield10 common stock on May 2, 2024, as adjusted for the reverse stock split, by (ii) the number of shares of common stock held by the stockholder that would otherwise have been exchanged for such fractional share interest.
The Company's transfer agent, Equiniti Trust Company, LLC, will act as its exchange agent for the reverse stock split. Registered stockholders holding pre-split shares of the Company’s common stock are not required to take any action to receive post-split shares. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers' particular processes, and will not be required to take any action in connection with the reverse stock split. Equiniti Trust Company, LLC can be reached at (800) 937-5449.
Additional information about the reverse stock split can be found in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 4, 2024, a copy of which is available at www.sec.gov or at www.yield10bio.com under the SEC Filings tab located on the Investors page of the Company’s website at www.yield10bio.com.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA biomaterials for use as biodegradable bioplastics. Subject to the availability of sufficient financial resources to continue operations, our commercial plan is based on establishing a grain contracting business leveraging our proprietary elite Camelina seed varieties, focusing on the production of omega-3 oils for nutritional applications and partnering or licensing our advanced


Camelina gene technologies to biofuel value chain partners to support their goals of meeting the growing demand for low-carbon intensity feedstock oil. Yield10 is headquartered in Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc., located in Saskatoon, Canada.
For more information about the Company, please visit www.yield10bio.com, or follow the Company on X (formerly Twitter), Facebook and LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, statements regarding the Company's expectations for the impact of the reverse stock split on the market price of the Company’s stock and the Company’s ability to regain and maintain compliance with Nasdaq listing requirements, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the Company’s ability to secure adequate funding in the near term to continue operations and to remain listed on the Nasdaq Stock Market, as to which no assurance can be given, as well as the risks and uncertainties detailed in Yield10's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.
Contacts:
Yield10 Bioscience
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

 EX-101.SCH 4 yten-20240501.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 yten-20240501_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 yten-20240501_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type Amendment Flag Amendment Flag Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 7 yten-20240501_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 yield10logoa50.jpg GRAPHIC begin 644 yield10logoa50.jpg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htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 01, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 01, 2024
Entity Registrant Name YIELD10 BIOSCIENCE, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-33133
Entity Tax Identification Number 04-3158289
Entity Address, Address Line One 19 Presidential Way
Entity Address, City or Town Woburn
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01801
City Area Code 617
Local Phone Number 583-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Central Index Key 0001121702
Amendment Flag false
Title of 12(b) Security Common stock, par value $0.01 per share
Trading Symbol YTEN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Document Information [Line Items]  
Current Fiscal Year End Date --12-31

EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://yield10bio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports yten-20240501.htm yten-20240501.xsd yten-20240501_def.xml yten-20240501_lab.xml yten-20240501_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "yten-20240501.htm": { "nsprefix": "yten", "nsuri": "http://yield10bio.com/20240501", "dts": { "inline": { "local": [ "yten-20240501.htm" ] }, "schema": { "local": [ "yten-20240501.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "yten-20240501_def.xml" ] }, "labelLink": { "local": [ "yten-20240501_lab.xml" ] }, "presentationLink": { "local": [ "yten-20240501_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://yield10bio.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "yten-20240501.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "yten-20240501.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 18 0001628280-24-019490-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-24-019490-xbrl.zip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end XML 20 yten-20240501_htm.xml IDEA: XBRL DOCUMENT 0001121702 2024-05-01 2024-05-01 0001121702 false --12-31 8-K 2024-05-01 YIELD10 BIOSCIENCE, INC. DE 001-33133 04-3158289 19 Presidential Way Woburn MA 01801 617 583-1700 false false false false Common stock, par value $0.01 per share YTEN NASDAQ false